CYTK vs GEN · rev $88.0M vs P/E 17, rev $5.00B
Cytokinetics Inc (CYTK) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported CYTK revenue for 2025-12-31 was $88.0M. Net income was -$785.0M. Revenue was up 376.6% from 2024-12-31 to 2025-12-31. CYTK currently screens at market cap $4.05B.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
CYTK currently screens at market cap $4.05B. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the CYTK and GEN stock pages for the full models.
Not investment advice.